Navigation Links
Penn scientist receives L'Oréal USA fellowship for women in science
Date:6/4/2008

PHILADELPHIA- Sara Aton, PhD, Postdoctoral Fellow in the Department of Neuroscience at the University of Pennsylvania School of Medicine, was awarded a grant from the L'Oral USA For Women in Science Program. Laurent Attal, President and CEO, L'Oral USA, and Dr. Ralph J. Cicerone, President, National Academy of Sciences, honored Dr. Aton, along with the other five 2008 recipients at the American Museum of Natural History in New York City. This prestigious fellowship provides support to postdoctoral women scientists who are undertaking cutting-edge research with practical applications.

"I was surprised and delighted when I found out that I had been selected for the L'Oreal award," said Dr. Aton. "The work of this year's fellows has real potential to change our world. So to say I am honored to have been placed among them is an understatement."

The L'Oral USA Fellowship program started in 2003 and each year identifies and rewards five female, postdoctoral researchers with grants. Starting in 2007, the grants doubled in value from $20,000 to $40,000.

Dr. Aton will use this grant to study a key biological component underlying learning and memory called synaptic plasticity. She studies the role of connections between nerve cells in consolidating ocular dominance plasticity during sleep by recording large groups of individual neurons in freely sleeping animals. Ocular dominance plasticity is a term that describes the remodeling of nerve synapses that occurs in the visual cortex of the brain in response to changes in visual input from both eyes.

"Because sleep seems to also be involved in learning and memory consolidation, we use ocular dominance plasticity as a system to probe the general mechanisms by which sleep may facilitate learning and memory," she explains.

This will be the first study attempting such large-scale recording of neurons within a synaptically-integrated network during plastic remodeling. Dr. Aton adds, "The L'Oreal For Women in Science Fellowship will allow me to purchase the equipment required to address this issue."

The results of this research will lay the foundation for continued study of how sleep affects cognition and how sleep deprivation adversely affects neural function. "The data we will be able to collect from this experiment may lead to major breakthroughs in our understanding of what goes on in the brain during sleep, how it differs from activity during waking, and what these differences mean for brain function," comments Dr. Aton.

This research may reveal implications and possible solutions for those who are confined to restricted sleep schedules. The long-term goal of Dr. Aton's research is to clarify how sleep contributes to learning and memory.


'/>"/>

Contact: Karen Kreeger
Karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Related medicine news :

1. CSHL scientists trace causal link between a tumor suppressor gene and liver cancer
2. Scientists develop cyborg engineering for coronary bypass grafting
3. Scientist study bacterial communities inside us to better understand health and disease
4. Weizmann Institute scientists develop a new approach to treating autoimmune disease
5. Blocking signaling protein prevents prostate cancer spread, Jefferson scientists find
6. NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting
7. World-Renowned Scientists to Lead Immunology Course
8. NYP/Columbia physician-scientists present at ASCO 44th annual meeting
9. Scripps Research scientists find seizure drug reverses cellular effects
10. Kavli Prize awarded to Pasko Rakic, pioneering Yale neuroscientist
11. Scientists Break Into HIV Hideout
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Penn scientist receives L'Oréal USA fellowship for women in science
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology: